# Ambow Education Holding Ltd.: financial statements, quarterly

AMBO · NYSE · CIK 1494558 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ambo.md) · [Financials](/companies/ambo/financials.md) · [Filings](/companies/ambo/filings.md) · [Insiders](/companies/ambo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ambo/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,314](/filings/0001213900-26-054457.md) | [2,766](/filings/0001213900-26-090008.md) | [2,799](/filings/0001213900-26-054457.md) | [2,393](/filings/0001213900-26-090008.md) |
| Cost of revenue | $k | [978](/filings/0001213900-26-054457.md) | [1,291](/filings/0001213900-26-090008.md) | [1,113](/filings/0001213900-26-054457.md) | [1,163](/filings/0001213900-26-090008.md) |
| Gross profit | $k | [1,336](/filings/0001213900-26-054457.md) | [1,475](/filings/0001213900-26-090008.md) | [1,686](/filings/0001213900-26-054457.md) | [1,230](/filings/0001213900-26-090008.md) |
| Research and development | $k | [101](/filings/0001213900-26-054457.md) | [102](/filings/0001213900-26-090008.md) | [156](/filings/0001213900-26-054457.md) | [220](/filings/0001213900-26-090008.md) |
| Operating income | $k | [138](/filings/0001213900-26-054457.md) | [329](/filings/0001213900-26-090008.md) | [442](/filings/0001213900-26-054457.md) | [(128)](/filings/0001213900-26-090008.md) |
| Interest expense | $k | [12.0](/filings/0001213900-26-054457.md) | [29.0](/filings/0001213900-26-090008.md) | [(16.0)](/filings/0001213900-26-054457.md) | [5.0](/filings/0001213900-26-090008.md) |
| Income tax | $k | not reported | [47.0](/filings/0001213900-26-090008.md) | [10.0](/filings/0001213900-26-054457.md) | [4.0](/filings/0001213900-26-090008.md) |
| Net income | $k | [109](/filings/0001213900-26-090008.md) | [1,775](/filings/0001213900-26-090008.md) | [424](/filings/0001213900-26-090008.md) | [(146)](/filings/0001213900-26-090008.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001213900-26-054457.md) | [0.03](/filings/0001213900-26-090008.md) | [0.01](/filings/0001213900-26-054457.md) | [(0.00)](/filings/0001213900-26-090008.md) |
| Basic EPS | $ per share | [0.00](/filings/0001213900-26-054457.md) | [0.03](/filings/0001213900-26-090008.md) | [0.01](/filings/0001213900-26-054457.md) | [(0.00)](/filings/0001213900-26-090008.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2021 (2021-12-31) | period not labelled (2022-10-11) | period not labelled (2022-10-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-01-31) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.7](/filings/0001410578-22-001124.md) | not reported | not reported | [3.3](/filings/0001104659-24-051943.md) | [0.3](/filings/0001013762-25-004136.md) | not reported | [1.1](/filings/0001213900-26-016592.md) | not reported | not reported | [0.8](/filings/0001213900-26-090008.md) | [4.2](/filings/0001213900-26-054457.md) | [4.5](/filings/0001213900-26-090008.md) |
| Current assets | $m | [70.3](/filings/0001410578-22-001124.md) | not reported | not reported | [15.8](/filings/0001104659-24-051943.md) | [12.5](/filings/0001013762-25-004136.md) | not reported | [11.6](/filings/0001213900-26-016592.md) | not reported | not reported | [10.9](/filings/0001213900-26-090008.md) | [10.5](/filings/0001213900-26-054457.md) | [9.4](/filings/0001213900-26-090008.md) |
| Total assets | $m | [152](/filings/0001410578-22-001124.md) | not reported | not reported | [25.5](/filings/0001104659-24-051943.md) | [20.6](/filings/0001013762-25-004136.md) | not reported | [17.4](/filings/0001213900-26-016592.md) | not reported | not reported | [20.8](/filings/0001213900-26-090008.md) | [20.1](/filings/0001213900-26-054457.md) | [19.2](/filings/0001213900-26-090008.md) |
| Current liabilities | $m | [94.7](/filings/0001410578-22-001124.md) | not reported | not reported | [11.9](/filings/0001104659-24-051943.md) | [9.8](/filings/0001013762-25-004136.md) | not reported | [6.8](/filings/0001213900-26-016592.md) | not reported | not reported | [4.9](/filings/0001213900-26-090008.md) | [4.2](/filings/0001213900-26-054457.md) | [3.8](/filings/0001213900-26-090008.md) |
| Total liabilities | $m | [129](/filings/0001410578-22-001124.md) | not reported | not reported | [17.6](/filings/0001104659-24-051943.md) | [14.1](/filings/0001013762-25-004136.md) | not reported | [10.6](/filings/0001213900-26-016592.md) | not reported | not reported | [12.5](/filings/0001213900-26-090008.md) | [11.4](/filings/0001213900-26-054457.md) | [10.6](/filings/0001213900-26-090008.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.7](/filings/0001213900-26-090008.md) | [2.7](/filings/0001213900-26-054457.md) | [2.7](/filings/0001213900-26-090008.md) |
| Short-term borrowings | $m | [1.6](/filings/0001410578-22-001124.md) | [1.5](/filings/0001013762-25-004136.md) | [1.5](/filings/0001213900-26-090008.md) | [3.0](/filings/0001104659-24-051943.md) | [3.9](/filings/0001013762-25-004136.md) | [1.2](/filings/0001213900-26-090008.md) | [2.7](/filings/0001213900-26-016592.md) | not reported | not reported | [0.5](/filings/0001213900-26-090008.md) | [0.5](/filings/0001213900-26-054457.md) | [0.5](/filings/0001213900-26-090008.md) |
| Shareholders' equity | $m | [22.9](/filings/0001410578-22-001124.md) | not reported | not reported | [7.9](/filings/0001410578-23-000821.md) | [6.4](/filings/0001213900-26-016592.md) | not reported | [6.7](/filings/0001213900-26-090008.md) | [6.8](/filings/0001213900-26-090008.md) | [8.6](/filings/0001213900-26-090008.md) | [8.3](/filings/0001213900-26-090008.md) | [8.7](/filings/0001213900-26-090008.md) | [8.6](/filings/0001213900-26-090008.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(923)](/filings/0001213900-26-054457.md) | [1,901 d](/filings/0001213900-26-090008.md) | [(1,189)](/filings/0001213900-26-054457.md) | [1,067 d](/filings/0001213900-26-090008.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.1](/filings/0001213900-26-054457.md) | [57.1](/filings/0001213900-26-090008.md) | [57.1](/filings/0001213900-26-054457.md) | [57.1](/filings/0001213900-26-090008.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.